Stallion India Fluorochemicals Limited has informed the Exchange regarding 'Earning Release on Audited Financial Results for the Quarter and Financial Year ended 31st March, 2025'.
STALLION · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Stallion India Fluorochemicals reported strong FY25 results, with total revenue rising to ₹379.47 crore from ₹236.23 crore in FY24, a growth of about 60%. EBITDA grew to ₹49.74 crore (FY24: ₹26.85 crore) and profit after tax more than doubled to ₹32.33 crore (FY24: ₹15.47 crore). For Q4 FY25 alone, revenue jumped nearly 80% sequentially to ₹153.16 crore, with EBITDA of ₹20.31 crore and PAT of ₹13.27 crore. FY25 results were weighed down by a one-time provision of ₹10.71 crore to settle an old legal claim with Sanmei; excluding this, PAT would have been ₹43.04 crore. Management guided for a 30–35% CAGR over the next three years, supported by upcoming semiconductor and specialty gas projects.
Strong topline growth, healthy margin expansion, and sharp doubling of annual PAT are clearly positive for shareholders. However, investors should note the ₹10.71 crore one-time legal provision that dented reported earnings.